PWMG
EDIT icon

Provence Wealth Management Group’s Editas Medicine EDIT Stock Holding History

Provence Wealth Management Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.88K Hold
284
– – ﹤0.01% 388
2023
Q3 		$2.21K Buy
+284
New +$2.44K ﹤0.01% 399

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Provence Wealth Management Group's EDIT Position: Q4 2023 in Review

Provence Wealth Management Group held its Editas Medicine (EDIT) position steady in Q4 2023 at 284 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #388.

Provence Wealth Management Group first reported a position in EDIT in Q3 2023 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold EDIT as of Q4 2023.

  • Provence Wealth Management Group held 284 shares of Editas Medicine worth $2.88K as of Q4 2023.
  • Provence Wealth Management Group left its Editas Medicine share count unchanged in Q4 2023.
  • Editas Medicine made up ﹤0.01% of Provence Wealth Management Group's portfolio in Q4 2023, its #388 holding.
  • Provence Wealth Management Group first reported a position in Editas Medicine in Q3 2023 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.